fibrinogen has been researched along with Infectious Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Gautreaux, MA; Person, XJ; Priddy, LB; Tucker, LJ; Zetterholm, HK | 1 |
| Chang, B; Li, S; Shen, Y; Wang, N | 1 |
| Cherny, I; Lahav, M; Rabizadeh, E; Shepshelovich, D | 1 |
| Demmers, S; Hultén, C | 1 |
| Betts, CM; Dal Monte, PR; Foschini, MP; Macchia, S; Marucci, G; Morandi, L; Pession, A; Tardio, ML | 1 |
| KNOBLOCH, H; SCHULZ, FH | 1 |
| KIRSCH, K; SCHULZ, FH | 1 |
| Didenko, VM; Zaĭde, GG | 1 |
| Forrester, T; Jahoor, F; Morlese, JF | 1 |
| Gurfinkel, EP | 1 |
| Blombäck, M; Brodin, B; Cedergren, B; Hesselvik, F; Lieden, G; Maller, R; Strindberg, J | 1 |
2 review(s) available for fibrinogen and Infectious Diseases
| Article | Year |
|---|---|
Review of immunological plasma markers for longitudinal analysis of inflammation and infection in rat models.
Topics: Acute-Phase Proteins; Animals; Arthritis; Biomarkers; Communicable Diseases; Cytokines; Female; Fibrinogen; Inflammation; Pregnancy; Pregnancy-Associated alpha 2-Macroglobulins; Rats | 2022 |
Fibrinogen and infection.
Topics: Animals; Arteriosclerosis; Communicable Diseases; Fibrinogen; Humans; Risk Factors | 1999 |
1 trial(s) available for fibrinogen and Infectious Diseases
| Article | Year |
|---|---|
Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombins; Blood Donors; Communicable Diseases; Disseminated Intravascular Coagulation; Factor VIII; Factor XII; Fibrinogen; Fibronectins; Humans; Middle Aged; Plasminogen; Reference Values | 1985 |
8 other study(ies) available for fibrinogen and Infectious Diseases
| Article | Year |
|---|---|
Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites.
Topics: Albumins; Communicable Diseases; Fibrinogen; Humans; Lactic Acid; Prognosis; Retrospective Studies; ROC Curve; Sepsis; Shock, Septic | 2022 |
[THE EFFECT OF INFECTIOUS AND AUTOIMMUNE DISEASES ON PROCOAGULANT ACTIVITY OF FIBRINOGEN-LIKE PROTEIN 2 IN THE PERIPHERAL BLOOD].
Topics: Autoimmune Diseases; Blood Coagulation; Communicable Diseases; Fibrinogen; Humans; Thromboplastin | 2019 |
Serum amyloid A (SAA) as an aid in the management of infectious disease in the foal: comparison with total leucocyte count, neutrophil count and fibrinogen.
Topics: Animals; Animals, Newborn; Communicable Diseases; Diagnosis, Differential; Diarrhea; Fibrinogen; Horse Diseases; Horses; Leukocyte Count; Neutrophils; Pneumonia, Bacterial; Prospective Studies; Serum Amyloid A Protein | 2002 |
Fibrinogen storage disease without hypofibrinogenaemia associated with acute infection.
Topics: Acute Disease; Afibrinogenemia; Aged; Bronchopneumonia; Communicable Diseases; Diarrhea; Female; Fibrinogen; Hepatocytes; Humans; Liver Diseases | 2003 |
[Effect of age on fibrinogen decrease and rate of fibrinolysis during epidemic hepatitis].
Topics: Afibrinogenemia; Aging; Communicable Diseases; Fibrin; Fibrinogen; Fibrinolysis; Hepatitis; Hepatitis A; Humans | 1955 |
[Age-dependant and sexually dualistic behavior of fibrinogen in pneumonia and in epidemic hepatitis].
Topics: Communicable Diseases; Fibrinogen; Hepatitis; Hepatitis A; Humans; Pneumonia | 1957 |
[Certain factors increasing the risk of local infectious complications following closed mitral commissurotomy].
Topics: Adolescent; Adult; Communicable Diseases; Female; Fibrinogen; Humans; Leukopenia; Male; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Postoperative Complications; Risk; Surgical Wound Infection | 1980 |
Acute-phase protein response to infection in severe malnutrition.
Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Child; Communicable Diseases; Deuterium; Dietary Proteins; Energy Intake; Female; Fibrinogen; Fluid Therapy; Haptoglobins; Humans; Leucine; Male; Orosomucoid; Protein-Energy Malnutrition; Time Factors | 1998 |